These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2149467)

  • 1. Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.
    Calame W; Guiot HF; Mattie H
    Scand J Infect Dis; 1990; 22(6):717-23. PubMed ID: 2149467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection.
    Calame W; van der Waals R; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1989 Jun; 33(6):980-2. PubMed ID: 2764550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone.
    Calame W; Douwes-Idema AE; van den Barselaar MT; van Furth R; Mattie H
    J Infect; 1994 Jul; 29(1):53-66. PubMed ID: 7963636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis.
    Danias PG; Chalevelakis G; Mylonakis EE; Argyropoulou A; Paniara O; Saroglou G; Raptis SA
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):51-4. PubMed ID: 9791758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of erythromycin and clindamycin in an experimental Staphylococcus aureus infection in normal and granulocytopenic mice. A comparative in vivo and in vitro study.
    Hoogeterp JJ; Mattie H; van Furth R
    Scand J Infect Dis; 1993; 25(1):123-32. PubMed ID: 8460336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ether oxime derivatives of erythromycin A. A structure-activity relationship study.
    Gasc JC; d'Ambrieres SG; Lutz A; Chantot JF
    J Antibiot (Tokyo); 1991 Mar; 44(3):313-30. PubMed ID: 1827435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of rifampicin against Staphylococcus aureus in vitro and in an experimental infection in normal and granulocytopenic mice.
    Hoogeterp JJ; Mattie H; Krul AM; van Furth R
    Scand J Infect Dis; 1988; 20(6):649-56. PubMed ID: 2975827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential concentration of azithromycin in an infected mouse thigh model.
    Retsema JA; Bergeron JM; Girard D; Milisen WB; Girard AE
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():5-16. PubMed ID: 8396096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
    Girard D; Bergeron JM; Milisen WB; Retsema JA
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():17-28. PubMed ID: 8396089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
    Veber B; Pocidalo JJ
    Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection.
    Hoogeterp JJ; Mattie H; Krul AM; van Furth R
    Antimicrob Agents Chemother; 1987 Jun; 31(6):930-4. PubMed ID: 3619426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
    Pascual A; López-López G; Aragón J; Perea EJ
    Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics.
    Mattie H
    Scand J Infect Dis Suppl; 1990; 74():133-6. PubMed ID: 2129065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilms formed by Staphylococcus aureus.
    Yamasaki O; Akiyama H; Toi Y; Arata J
    J Antimicrob Chemother; 2001 Oct; 48(4):573-7. PubMed ID: 11581241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
    Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
    Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of etoposide and cyclophosphamide on an experimental pulmonary infection in mice.
    Calame W; Mattie H
    Agents Actions; 1989 Jan; 26(1-2):77-8. PubMed ID: 2653009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus.
    Nibbering PH; Welling MM; Paulusma-Annema A; Brouwer CP; Lupetti A; Pauwels EK
    J Nucl Med; 2004 Feb; 45(2):321-6. PubMed ID: 14960656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.
    Hoogeterp JJ; Mattie H; Krul AM; Terporten P; van Furth R
    Scand J Infect Dis; 1989; 21(1):95-101. PubMed ID: 2727631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.